Why are sodium channel modulators not yet pharmacotherapeutic trailblazers for neuropathic pain?
出版年份 2021 全文链接
标题
Why are sodium channel modulators not yet pharmacotherapeutic trailblazers for neuropathic pain?
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-3
出版商
Informa UK Limited
发表日期
2021-04-27
DOI
10.1080/14656566.2021.1917548
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neuropathic Pain: Mechanism-Based Therapeutics
- (2020) Kirsty Bannister et al. Annual Review of Pharmacology and Toxicology
- Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy
- (2020) Julie IR Labau et al. BRAIN
- Reliability and Validity of the Boston Bedside Quantitative Sensory Testing Battery for Neuropathic Pain
- (2020) Alexandra E Koulouris et al. PAIN MEDICINE
- Defining the Functional Role of NaV1.7 in Human Nociception
- (2019) Lucy A. McDermott et al. NEURON
- Sodium Channels in Human Pain Disorders: Genetics and Pharmacogenomics
- (2019) Sulayman D. Dib-Hajj et al. Annual Review of Neuroscience
- A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
- (2019) Jan C. Otto et al. Frontiers in Neurology
- Effect of lacosamide in peripheral neuropathic pain: study protocol for a randomized, placebo-controlled, phenotype-stratified trial
- (2019) Malin E. Carmland et al. Trials
- Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy
- (2018) Aoibhinn McDonnell et al. PAIN
- Neuropathy following spinal nerve injury shares features with the irritable nociceptor phenotype: A back-translational study of oxcarbazepine
- (2018) Ryan Patel et al. EUROPEAN JOURNAL OF PAIN
- Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial
- (2018) Bianca T A de Greef et al. BRAIN
- Pain relief in a neuropathy patient by lacosamide: Proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors
- (2018) Barbara Namer et al. EBioMedicine
- Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial
- (2017) Joanna M Zakrzewska et al. LANCET NEUROLOGY
- Peripheral neuropathic pain
- (2017) Ralf Baron et al. PAIN
- Rare Nav1.7 variants associated with painful diabetic peripheral neuropathy
- (2017) Iulia Blesneac et al. PAIN
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
- (2015) Nanna B Finnerup et al. LANCET NEUROLOGY
- Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat
- (2015) W. Rahman et al. NEUROSCIENCE
- The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study
- (2014) Dyveke T. Demant et al. PAIN
- Gain-of-function Nav1.8 mutations in painful neuropathy
- (2012) C. G. Faber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons
- (2012) Michael S. Minett et al. Nature Communications
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search